Viewing Study NCT02787369


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-02-25 @ 8:18 PM
Study NCT ID: NCT02787369
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-01
First Post: 2016-05-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module